Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Walmart | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | USD 758.67B | 38.8x | 1.91 | USD 94.09 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.3% Upside | Upgrade to Pro+ | |
Kroger | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | USD 45.89B | 16.6x | 0.33 | USD 63.30 | 3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.5% Upside | Upgrade to Pro+ | |
Seven i ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | USD 42.82B | 33.7x | -2.9 | USD 16.40 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Seven & i Co | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | USD 42.82B | 33.7x | -2.9 | USD 16.10 | -7.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sysco | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | USD 39.21B | 20.5x | 2.13 | USD 79.71 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.8% Upside | Upgrade to Pro+ | |
Fomento Economico Mexicano | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | USD 32.03B | 27.9x | -0.3 | USD 88.55 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.3% Upside | Upgrade to Pro+ | |
Tesco PLC | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | USD 31.59B | 19.7x | -2.86 | USD 14.18 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.9% Upside | Upgrade to Pro+ | |
Tesco PLC | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | USD 31.59B | 19.7x | -2.86 | USD 4.71 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Koninklijke Ahold NV | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | USD 31.10B | 16.4x | -1.11 | USD 33.43 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Koninklijke Ahold ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | USD 31.10B | 16.4x | -1.1 | USD 33.67 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.1% Upside | Upgrade to Pro+ | |
Aeon ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | USD 21.45B | 122x | USD 25.01 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
CP All ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | USD 16.55B | 24.1x | 0.53 | USD 20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
US Foods | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | USD 16.10B | 29.4x | 1 | USD 68.96 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.3% Upside | Upgrade to Pro+ | |
Coles Group | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | USD 16.06B | 22.4x | 12.42 | USD 9.60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Caseys | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | USD 15.79B | 29.4x | 2.71 | USD 425.70 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -2.1% Downside | Upgrade to Pro+ | |
Sprouts Farmers | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | USD 14.94B | 42.7x | 1 | USD 149.51 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -11.7% Downside | Upgrade to Pro+ | |
Performance Food Group Co | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | USD 13.76B | 32.3x | 45.77 | USD 88.20 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.5% Upside | Upgrade to Pro+ | |
Jeronimo Martins SGPS SA ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | USD 12.34B | 18.4x | -1.46 | USD 39.28 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25.2% Upside | Upgrade to Pro+ | |
Albertsons | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | USD 11.07B | 11x | -0.91 | USD 19.12 | 4.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.2% Upside | Upgrade to Pro+ | |
Marks & Spencer Group Plc | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | USD 9.89B | 15.4x | 0.66 | USD 9.79 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.8% Upside | Upgrade to Pro+ | |
Marks and Spencer | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | USD 9.89B | 15.4x | 0.66 | USD 5.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dino Polska ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | USD 9.81B | 28.2x | 8.73 | USD 51 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Carrefour SA PK | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | USD 9.80B | 11.9x | -0.2 | USD 2.89 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.6% Upside | Upgrade to Pro+ | |
Shoprite ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | USD 9.52B | 27x | 4.12 | USD 17.27 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Walgreens Boots | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | USD 8.37B | -1x | 0 | USD 9.73 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.6% Upside | Upgrade to Pro+ | |
J Sainsbury PLC | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | USD 8.26B | 111.8x | -1.34 | USD 14.50 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -11.5% Downside | Upgrade to Pro+ | |
Kesko ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | USD 7.93B | 18x | -0.91 | USD 10.01 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Luckin Coffee | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | USD 7.17B | 23.2x | -2.45 | USD 23.83 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 41.3% Upside | Upgrade to Pro+ | |
Raia Drogasil ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | USD 7.03B | 37.1x | 8.83 | USD 4.13 | -14.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 36.4% Upside | Upgrade to Pro+ | |
Sendas Distribuidora | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | USD 6.91B | 65.6x | -0.58 | USD 5.09 | -6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |